Chemistry Services

Aizawl, India

Chemistry Services

Aizawl, India
SEARCH FILTERS
Time filter
Source Type

This report studies Drug Discovery Outsourcing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Request a Sample Report @ https://www.wiseguyreports.com/sample-request/963107-global-drug-discovery-outsourcing-market-research-report-2017 Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Drug Discovery Outsourcing in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Libraries Building Blocks Compound Synthesis Target Validation Split by application, this report focuses on consumption, market share and growth rate of Drug Discovery Outsourcing in each application, can be divided into Chemistry Services Biology Services Lead Optimisation Lead Identification and Screening Global Drug Discovery Outsourcing Market Research Report 2017 1 Drug Discovery Outsourcing Market Overview 1.1 Product Overview and Scope of Drug Discovery Outsourcing 1.2 Drug Discovery Outsourcing Segment by Type 1.2.1 Global Production Market Share of Drug Discovery Outsourcing by Type in 2015 1.2.2 Libraries 1.2.3 Building Blocks 1.2.4 Compound Synthesis 1.2.5 Target Validation 1.3 Drug Discovery Outsourcing Segment by Application 1.3.1 Drug Discovery Outsourcing Consumption Market Share by Application in 2015 1.3.2 Chemistry Services 1.3.3 Biology Services 1.3.4 Lead Optimisation 1.3.5 Lead Identification and Screening 1.4 Drug Discovery Outsourcing Market by Region 1.4.1 North America Status and Prospect (2012-2022) 1.4.2 Europe Status and Prospect (2012-2022) 1.4.3 China Status and Prospect (2012-2022) 1.4.4 Japan Status and Prospect (2012-2022) 1.4.5 Southeast Asia Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Drug Discovery Outsourcing (2012-2022) 7 Global Drug Discovery Outsourcing Manufacturers Profiles/Analysis 7.1 Albany Mlecular Research (AMRI) 7.1.1 Company Basic Information, Manufacturing Base and Its Competitors 7.1.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.1.2.1 Libraries 7.1.2.2 Building Blocks 7.1.3 Albany Mlecular Research (AMRI) Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.1.4 Main Business/Business Overview 7.2 Aptuit 7.2.1 Company Basic Information, Manufacturing Base and Its Competitors 7.2.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.2.2.1 Libraries 7.2.2.2 Building Blocks 7.2.3 Aptuit Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.2.4 Main Business/Business Overview 7.3 Charles River Labratries 7.3.1 Company Basic Information, Manufacturing Base and Its Competitors 7.3.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.3.2.1 Libraries 7.3.2.2 Building Blocks 7.3.3 Charles River Labratries Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.3.4 Main Business/Business Overview 7.4 Cvance 7.4.1 Company Basic Information, Manufacturing Base and Its Competitors 7.4.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.4.2.1 Libraries 7.4.2.2 Building Blocks 7.4.3 Cvance Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.4.4 Main Business/Business Overview 7.5 Cyprtex 7.5.1 Company Basic Information, Manufacturing Base and Its Competitors 7.5.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.5.2.1 Libraries 7.5.2.2 Building Blocks 7.5.3 Cyprtex Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.5.4 Main Business/Business Overview 7.6 Dmainex 7.6.1 Company Basic Information, Manufacturing Base and Its Competitors 7.6.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.6.2.1 Libraries 7.6.2.2 Building Blocks 7.6.3 Dmainex Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.6.4 Main Business/Business Overview 7.7 Evtec 7.7.1 Company Basic Information, Manufacturing Base and Its Competitors 7.7.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.7.2.1 Libraries 7.7.2.2 Building Blocks 7.7.3 Evtec Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.7.4 Main Business/Business Overview 7.8 GenScript 7.8.1 Company Basic Information, Manufacturing Base and Its Competitors 7.8.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.8.2.1 Libraries 7.8.2.2 Building Blocks 7.8.3 GenScript Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.8.4 Main Business/Business Overview 7.9 Pharmaceutical Prduct Develpment (PPD) 7.9.1 Company Basic Information, Manufacturing Base and Its Competitors 7.9.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.9.2.1 Libraries 7.9.2.2 Building Blocks 7.9.3 Pharmaceutical Prduct Develpment (PPD) Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.9.4 Main Business/Business Overview 7.10 Quintiles 7.10.1 Company Basic Information, Manufacturing Base and Its Competitors 7.10.2 Drug Discovery Outsourcing Product Type, Application and Specification 7.10.2.1 Libraries 7.10.2.2 Building Blocks 7.10.3 Quintiles Drug Discovery Outsourcing Production, Revenue, Price and Gross Margin (2015 and 2016) 7.10.4 Main Business/Business Overview 7.11 Selcia 7.12 Viva Bitech 7.13 WIL Research Labratries 7.14 WuXi AppTec For more information, please visit https://www.wiseguyreports.com/sample-request/963107-global-drug-discovery-outsourcing-market-research-report-2017


Surakanti R.,Chemistry Services | Surakanti R.,Andhra University | Sanivarapu S.,Chemistry Services | Sanivarapu S.,Gokaraju Rangaraju Institute of Engineering and Technology | And 8 more authors.
Chemistry - An Asian Journal | Year: 2013

An elegant reagent-controlled strategy has been developed for the generation of a diverse range of biologically active scaffolds from a chiral bicyclic lactam. Reduction of the chiral lactam with LAH or alkylation with LHMDS to trigger different cyclization reactions have been shown to generate privileged scaffolds, such as pyrrolidines, indolines, and cyclotryptamines. Their amenability to substitution allows us to create various compound libraries by using these scaffolds. In silico studies were used to estimate the drug-like properties of these compounds. Selected compounds were subjected to anticancer screening by using three different cell lines. In addition, all these compounds were subjected to antibacterial screening to gauge the spectrum of biological activity that was conferred by our DOS methodology. Gratifyingly, with no additional iterative cycles, our method directly generated anticancer compounds with potency at low nanomolar concentrations, as represented by spiroindoline 14. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.


PubMed | Chemistry Services
Type: Journal Article | Journal: Chemistry, an Asian journal | Year: 2013

An elegant reagent-controlled strategy has been developed for the generation of a diverse range of biologically active scaffolds from a chiral bicyclic lactam. Reduction of the chiral lactam with LAH or alkylation with LHMDS to trigger different cyclization reactions have been shown to generate privileged scaffolds, such as pyrrolidines, indolines, and cyclotryptamines. Their amenability to substitution allows us to create various compound libraries by using these scaffolds. Insilico studies were used to estimate the drug-like properties of these compounds. Selected compounds were subjected to anticancer screening by using three different cell lines. In addition, all these compounds were subjected to antibacterial screening to gauge the spectrum of biological activity that was conferred by our DOS methodology. Gratifyingly, with no additional iterative cycles, our method directly generated anticancer compounds with potency at low nanomolar concentrations, as represented by spiroindoline 14.


News Article | February 15, 2017
Site: www.prnewswire.com

LONDON, Feb. 15, 2017 /PRNewswire/ -- Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening Report Details Where is the drug discovery outsourcing market heading? Visiongain's new report gives you revenue predictions for the drug discovery...

Loading Chemistry Services collaborators
Loading Chemistry Services collaborators